Medical Imaging Machines (Global Market)

Main Article: Medical Equipment (Global Market)

X-ray equipment

• X-Ray Equipment (Global Market)

2023

Sales of open-type MRI scanners in the world for the year reached $1.6 billion

At the end of 2023, sales of open-type magnetic resonance imaging (MRI) devices on a global scale reached $1.6 billion. The market is experiencing steady growth, driven by increasing demand for diagnostic imaging. This is stated in a study by Market Research Future, the results of which were released in mid-July 2024.

Open-type MRI scanners are special systems designed to conduct research without a tunnel capsule. Such devices provide more free space around the patient, thereby eliminating the feeling of cramped and closed. This is important for people with claustrophobia or limited mobility. The advantages of open-design equipment include versatility (used in a wide range of clinical trials), convenience (allows for examinations of patients of any build) and easy access of medical personnel.

Key market players include Hitachi Healthcare Americas,, Siemens Healthineers,, GE Healthcare Philips Healthcare Toshiba Medical Systems Corporation,,, Esaote S.p.A. Aspect Imaging Fonar Corporation, Paramed Medical Systems, Neusoft Medical Systems. From a geographical point of view, in 2023, North America became the largest sales region for open-type MRI scanners: it accounted for $0.7 billion, or about 44% of total sales. The Europe Asia-Pacific region, where the highest growth rates are observed, is in second place, and closes the top three.

Market Research Future analysts believe that in 2024 the costs in the area under consideration will rise to $1.7 billion. In the future, the CAGR (compound percentage CAGR) is expected to be 6%. As a result, by 2032, the global market for open-type MRI scanners could reach approximately $2.6 billion.^[1]

Global Breast Imaging Systems Market Growth by 12.5%

At the end of 2023, the volume of the global market for breast imaging systems in monetary terms increased by approximately 12.5% compared to 2022. Leading providers of such solutions include Hologic, GE HealthCare and Siemens Healthcare, according to a study by Signify Research, the results of which were published on January 31, 2024.

It is noted that in 2022, the total revenue of suppliers of breast imaging complexes decreased by 17.6% compared to 2021. This is due to the fact that manufacturers are faced with a lack of semiconductor components and difficulties in supply chains. In addition, the industry has been negatively impacted by rising inflation and cuts in health facility budgets. But the market returned to growth in 2023.

𝓲

Signify Research

As of 2023, digital tomosynthesis of the mammary glands accounts for more than half of all expenses in the segment under consideration. This method of X-ray mammography allows you to obtain pseudo-volumetric images of tissues and reduce the effect of superposition. The technology is popular in Western Europe, North America and Oceania.

The report by Signify Research says that developers of breast imaging systems are actively introducing artificial intelligence tools. According to forecasts, by 2027, the global market for AI solutions in the field of breast disease diagnostics will reach $233.9 million, of which more than two thirds will be in the American region. In general, by 2027, costs in the segment of breast imaging complexes can reach $1.18 billion. The growth of the market, according to analysts Signify Research, will be facilitated by new screening programs, digitalization of the medical industry in developing countries and other factors.^[2]

2021: Medical imaging equipment sales in 3D hit $11.83 billion for the year

In 2021, the global market for medical imaging equipment in 3D reached $11.83 billion. This was announced in mid-February 2022 by analysts at ResearchAndMarkets.

Medical imaging is a method of creating visual images of the internal organs of the body for the clinical diagnosis of the disease and its subsequent treatment.

Sales of medical imaging equipment in 3D for 2021 reached $11.83 billion

3D imaging technology allows healthcare professionals to capture images from different angles and study tissues at different depths, as well as with increased resolution and more complex details, allowing a better understanding of the human body. Unlike previously used imaging technologies, which may have provided erroneous results, 3D imaging technology offers accurate information in the diagnosis of any disease. This method has proved revolutionary in the diagnosis of various diseases, including breast tomosynthesis, which is crucial in the treatment of breast cancer.

A thriving healthcare industry is one of the key drivers of market growth, according to ResearchAndMarkets. There has been an increase in the incidence of lifestyle-related diseases along with age-related diseases due to sedentary lifestyle and a significant increase in the geriatric population. Consequently, this has increased the demand for 3D imaging equipment in the healthcare sector. In addition, technological advances coupled with a growing understanding of the benefits of this technology, such as accurate visual representation of internal organs, reduction of damage to surrounding tissues, and accuracy of data offered by various medical imaging procedures, have driven the growth of the market. The market is also driven by increased budgetary allocations for health care and research and development (R&D) by governments across the globe.

Among the major players in the medical imaging equipment market in 3D:

• GE Healthcare;
• Philips Healthcare;
• Siemens Healthineers
• Fujifilm;
• Analogic;
• ContextVision;
• Dentsply Sirona;
• EOS image;
• Esaote;
• Fuel 3D Technologies;
• GENDEX DENTAL SYSTEMS;
• Hologic;
• Intelerad Medical Systems;
• PLANMECA OY;
• Samsung Medison;
• Shimadzu Corpora et al.^[3]

2020

Mammography and breast ultrasound equipment sales plummet

The market size of equipment for mammographies ULTRASONOGRAPHY and mammary glands in 2020 decreased by slightly less than 15% and 18%, respectively. The increasing incidence rates breast cancer in the world, combined with problems in women requiring breast screening prescribing cancer due to, COVID-19 reinforce the importance of protecting women's health and early cancer detection. According to the World Health Organization WHO , breast cancer has surpassed the lung cancer most commonly diagnosed cancer in the world. This became known in November 2021.

According to a report by Signify Research, the global market for breast imaging equipment will reach almost $1.3 billion by 2024, and the market for artificial intelligence (AI) for breast imaging is $205 million. COVID-19 has seriously affected all medical procedures and medical institutions since the pandemic was declared worldwide in March 2020. Breast screening was significantly affected, with a large number of women missing scheduled mammograms.

Mammography and Breast Ultrasound Equipment Market Size in 2020 Decreased by Slightly Less Than 15% and 18%, Respectively

It is estimated that in 2020 the number of new cases will be 2.3 million, which corresponds to 11.7% of all new cases of cancer in the world. Breast cancer will also cause just under 690 thousand deaths worldwide in 2020. With the increasing incidence of breast cancer worldwide, there is increasing pressure on government screening programmes in various countries around the world. However, screening programs alone are not enough to address breast cancer mortality. It is necessary to increase the accuracy of breast cancer detection, as well as reduce the number of false positive results and missed lesions. These factors are projected to be at the forefront of breast imaging development, both for screening and diagnosis.

Sales of equipment for mammography and ultrasound of the mammary glands fell sharply at the end of 2020

In the United States, the Centers for Disease Control and Prevention (CDC) reported that in April 2020, when the country was largely closed, 80% fewer screening mammograms were performed compared to the average number of mammograms in April from 2014 to 2019. With such a significant number of women missing screening screenings, there are big fears that many more women will develop late-stage breast cancer between 2022 and 2024 as a result. However, it will take significant investment, both in medical staff and breast imaging equipment, to manage the backlog in patient admissions. With increased pressure on screening centers and hospitals to address the number of women requiring breast cancer screening, there has been increased interest in how AI can be used to determine the sequence of scans, highlighting suspicious cases or lesions. The most urgent cases can be considered as higher priorities in the radiologist's workflow and speed up patient care pathways or protocols for further diagnosis.

The United States is the only country that uses 3D mammography for screening on November 9, 2021, in all other countries, this technology is used only for diagnostic purposes. Western European countries are expected to be the next to accept screening programs using 3D mammography, but this will not happen until 2024. Advanced mammographic screening techniques such as AI, tomosynthesis-controlled biopsies, contrast-enhanced spectral mammography, and a more personalized approach to breast cancer screening are initiatives that may help reduce false negative or positive results and contribute to more accurate early detection of breast cancer.^[4]

Global Diagnostic Imaging Medical Device Market Size Reaches $42.17 Billion

The global market for medical devices for diagnostic imaging (CT, MRI, ultrasound scanners, etc.) at the end of 2020 reached $42.17 billion, having decreased by 0.6% compared to the previous year. Such figures were named by British Evaluate.

The leader of the market in question was the German company Siemens Healthineers, whose share in 2020 increased by 1 percentage point compared to 2019 and amounted to 24.6%. The second position was occupied by the Dutch Philips, which accounted for 20.3% of sales of medical imaging equipment against 20% a year earlier.

In the top three is still the American company GE Healthcare, whose share over the year decreased by almost 2 percentage points, to 19.7%. Following GE Healthcare is Japan's Canon, which in 2020 showed a 0.2 percentage point increase in market share, to 9.7%. Fujifilm Holdings also entered the top 5, which at the end of 2020 took 5.6% of the global market for diagnostic imaging systems. Compared to 2019, Fujifilm's share increased by 0.8 percentage points, which was the highest dynamics in the leading group.

The volume of the global market for medical devices for diagnostic imaging in 2020 reached $42.17 billion

The fall in the market for diagnostic imaging complexes in 2020 is caused by the consequences of the COVID-19 coronavirus pandemic, due to which most of the resources in healthcare were thrown into the fight against this infection. As a result, the volume of routine care and the number of surveys for non-communicable diseases decreased. The reduction in medical care during the first wave of coronavirus was observed in both round-the-clock and day hospitals.

Imaging for medical purposes covers the services of radiologists, radiologists, medical physicists and biomedical equipment engineers working together as part of one team for the best results, experts said. This ensures the provision of high-quality radiological services, followed by improved medical care.

The market for medical imaging systems purchased for diagnostic centers is estimated at $11 billion in 2020. Diagnostic centers offer treatment at lower costs compared to hospital facilities due to high operational efficiency. In addition, digitalization in the health sector leads to simplified diagnostics, faster and more accurate survey results, which further contributes to the growth of the segment.

Global Medical Imaging Device Market Leaders

Asia Pacific accounted for more than 23% of global revenue in 2020. Technological advances in medical imaging and the presence of numerous companies in the region will contribute to the development of the industry. In addition, the growing number of seniors in this region who require medical imaging products for better diagnosis, government projects, as well as increased health care costs are just some of the aspects that have a positive impact on the growth of the Asia-Pacific medvisualization equipment market, the study notes.

In 2020, there was a surge in demand for X-rays and CT scans of the chest, which is associated with the COVID-19 coronavirus pandemic. Experts are confident that this category of services and devices will continue to be in high demand.

The researchers point to two important trends that have been observed in 2020:

• the development of so-called precision medicine:
• growing use of imaging systems during screening, various kinds of therapies, and in surgery.

^[5]Leaders

2019: Medical Imaging Equipment Market Valued at $37.2 Billion for the Year

In 2018, global sales of diagnostic equipment for medical imaging reached $37.2 billion, according to the analytical company P&S Intelligence.

Experts called X-ray systems the largest segment of the market under consideration, the implementation of which in 2018 turned out to be $15.2 billion. It is expected that this segment will demonstrate annual growth at 5.2%, and in 2024 its volume will reach $20.5 billion. The entire market for medical visualization devices by this time will rise to $51.1 billion.

Global Sales of Diagnostic Medical Imaging Equipment Reach $37.2 Billion

The study also reports rapid growth in sales of radionuclide scanning systems, fuelled by the spread of cancers and high demand for such equipment around the world.

According to P&S Intelligence estimates, in 2018, sales of ultrasound scanners in the world amounted to $5.9 billion. It is predicted that by 2024 the figure will grow to $8.3 billion, and the segment will increase by about 6% per year.

The following companies are named the largest manufacturers of diagnostic imaging devices:

• General Electric;
• Philips;
• Siemens;
• Canon Medical Systems;
• Shimadzu;
• Carestream Health;
• Esaote;
• Fujifilm;
• Samsung;
• Hologic.

The report also lists several major market trends in 2018:

• an increase in the number of new products and their approvals by regulators;
• new joint projects of manufacturers;
• the takeover of companies by key players to expand the business and number of customers;
• launching programs by the authorities telling the population about the need for early diagnosis of diseases.

Diagnostic imaging systems improve the quality of medical care and reduce the cost of it, as well as speed up recovery after treatment and avoid unnecessary invasive procedures. Such factors play a key role in the growth of the diagnostic imaging systems market, analysts say.^[6]

2015: Market Size $30 Billion

In May 2016, the analytical company P&S Market Research published the results of a study of the global market for medical imaging devices. Its volume at the end of 2015 reached $29.9 billion. Most of the sales of diagnostic medical imaging equipment came from X-ray solutions. The researchers did not name the volume of their implementation.

In 2015, the market for medical imaging devices reached $30 billion

Experts listed several factors contributing to the growth of the global market for medical imaging devices: increased health care costs, increased public awareness of the need for early diagnosis, an increase in the number of elderly people on the planet, technological progress, the prevalence of chronic diseases and an increase in the number of medical imaging applications.

There are also barriers that prevent the market from developing: high regulatory requirements for technology, the risk of developing cancer as a result of radiation and a shortage of deposits of helium gas used in magnetic resonance imaging devices.

P&S Market Research predicts that in the period from 2016 to 2022, the global market for medical imaging devices will be able to grow by an average of 5% annually.^[7]

See also

Optical Medical Imaging Devices (Global Market)

Notes